Crossmark

Cinacalcet versus Placebo for secondary hyperparathyroidism in chronic kidney disease patients: a meta-analysis of randomized controlled trials and trial sequential analysis

Crossref DOI link: https://doi.org/10.1038/s41598-018-21397-8

Published Online: 2018-02-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Guoqi

Liu, Hongyan

Wang, Chengzhi

Ji, Xiaojian

Gu, Weijun

Mu, Yiming
License Information

Text and Data Mining valid from 2018-02-15

Version of Record valid from 2018-02-15
More Information

Article History

Received: 11 November 2016

Accepted: 1 February 2018

First Online: 15 February 2018

Competing Interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below